Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Hisern Medical Device CoBJSE:920166 20 EBITDA Margin % is 23.81% as of Jun. 2026, which is 31% below its 10-year median of 34.47. GuruFocus rates BJSE:920166 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 814 Medical Devices & Instruments companies, Zhejiang Hisern Medical Device Co ranks worse than 73.46% on this metric.
Zhejiang Hisern Medical Device Co (BJSE:920166) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Zhejiang Hisern Medical Device Co EBITDA Margin % Related Terms
Zhejiang Hisern Medical Device Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisern Medical Device Co EBITDA Margin % Chart
BJSE:920166 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Zhejiang Hisern Medical Device Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Hisern Medical Device Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Hisern Medical Device Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Hisern Medical Device Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisern Medical Device Co (BJSE:920166) has a EBITDA Margin % of 23.81% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zhejiang Hisern Medical Device Co and its competitors. This is 31% below median its historical median of 34.47. According to the industry distribution chart, Zhejiang Hisern Medical Device Co ranks #598 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 73.5%.
Is Zhejiang Hisern Medical Device Co's EBITDA Margin % too high?
Zhejiang Hisern Medical Device Co's current EBITDA Margin % of 23.81% is 31% below median its 10-year median of 34.47. The Medical Devices & Instruments industry median EBITDA Margin % is 8.08. Zhejiang Hisern Medical Device Co's value of 23.81% is 194.7% above this industry median. Based on the distribution chart, Zhejiang Hisern Medical Device Co ranks #598 out of 814 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zhejiang Hisern Medical Device Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisern Medical Device Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhejiang Hisern Medical Device Co ranks #598 out of 814 companies for EBITDA Margin %. This places Zhejiang Hisern Medical Device Co in the lower half of its industry. The industry median EBITDA Margin % is 8.08. Zhejiang Hisern Medical Device Co's value of 23.81% is 194.7% above this benchmark. While the company's 10-year median is 34.47 vs. the industry median of 8.08, Zhejiang Hisern Medical Device Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 8.08, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisern Medical Device Co's current EBITDA Margin % of 23.81% is 194.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zhejiang Hisern Medical Device Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 8.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisern Medical Device Co's current EBITDA Margin % is 23.81%, which is 31% below median its own 10-year median of 34.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisern Medical Device Co stock overvalued right now?
Zhejiang Hisern Medical Device Co (BJSE:920166) has a current EBITDA Margin % of 23.81%. The current EBITDA Margin % is 23.81%, which is 31% below median its 10-year median of 34.47 and 194.7% above the Medical Devices & Instruments industry median of 8.08. Zhejiang Hisern Medical Device Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Zhejiang Hisern Medical Device Co (BJSE:920166), the current EBITDA Margin % is 23.81% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Hisern Medical Device Co Ltd is engaged in the research and development, manufacturing, and sale of anesthesia and patient monitoring medical devices. The company's offerings include Analgesic series products, airway and respiratory management series products, spinal canal and nerve block series products and carbon dioxide absorber series products for anesthesia machines.
20GF Score
Get the complete analysis for BJSE:920166
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920166 has been successfully added to your 
